An update from Masimo ( (MASI) ) is now available.
Masimo Corporation reported strong financial results for Q3 2024, with consolidated revenue reaching $504.6 million, driven by an 11.5% increase in healthcare revenue. The company achieved a GAAP net income of $9.8 million and a non-GAAP net income of $52.9 million, reflecting its strategic focus on core healthcare segments and significant market opportunities. Masimo also provided an optimistic outlook for Q4 and adjusted full-year guidance, emphasizing long-term growth potential and increased shareholder value.
See more data about MASI stock on TipRanks’ Stock Analysis page.
